Efficacy of palonosetron to prevent delayed nausea and vomiting in non-Hodgkin’s lymphoma patients undergoing repeated cycles of the CHOP regimen-Reference-Cited by-同舟云学术

Efficacy of palonosetron to prevent delayed nausea and vomiting in non-Hodgkin’s lymphoma patients undergoing repeated cycles of the CHOP regimen

Published:2017-08-02 Issue:1 Volume:26 Page:269-274
ISSN:0941-4355
Container-title:Supportive Care in Cancer
language:en
Short-container-title:Support Care Cancer

Author:

Saito Bungo,Nakashima Hidetoshi,Abe Maasa,Murai So,Baba Yuta,Arai Nana,Kawaguchi Yukiko,Fujiwara Shun,Kabasawa Nobuyuki,Tsukamoto Hiroyuki,Uto Yui,Ariizumi Hirotsugu,Yanagisawa Kouji,Hattori Norimichi,Harada Hiroshi,Nakamaki Tsuyoshi

Publisher

Springer Science and Business Media LLC

Subject

Oncology

Link

http://link.springer.com/article/10.1007/s00520-017-3845-y/fulltext.html

Reference10 articles.

1. The Italian Group for Antiemetic (1995) Dexamethasone, granisetron, or both for the prevention of nausea and vomiting during chemotherapy of cancer. N Engl J Med 332:1–5

2. Geling O, Erchler HG (2005) Should 5-hydroxytryptamine-3 receptor antagonists be administered beyond 24 hours after chemotherapy to prevent delayed emesis? Systematic re-evaluation of clinical evidence and drug cost implications. J Clin Oncol 20:1289–1294

3. Saito M, Aogi K, Sekine I, Yoshizawa H, Yanagita Y, Sakai H, Inoue K, Kitagawa C, Ogura T, Mitsuhashi S (2009) Palonosetron plus dexamethasone versus granisetron plus dexamethasone for prevention of nausea and vomiting during chemotherapy: double-dummy, randomized, comparative phase III trial. Lancet Oncol 10:115–124

4. Di Renzo N, Montanini A, Mannina SD, Dondi A, Muci S, Mancuso S, De Paolis MR, Plati C, Stelitano C, Patti C, Olivieri A, Liardo E, Buda G, Cantaffa R, Federico M (2011) Single-dose palonosetrone for prevention of chemotherapy-induced nausea and vomiting in patients with aggressive non-Hodgkin’s lymphoma receiving moderately emetogenic chemotherapy containing steroids: results of phase II study from the Gruppo Italiano per lo studio dei Linfomi (GISL). Support Care Cancer 19:1505–1510

5. Choi BS, Borsaru GP, Ballinari G, Voisin D, Di Renzo N (2014) Multicenter phase IV study palonosetron in the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients with non-Hodgkin lymphomas undergoing repeated cycles of moderately emetogenic chemotherapy. Leuk. Lymphoma 55:544–550

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effectiveness of a provincial symptom assessment program in reaching adolescents and young adults with cancer: A population‐based cohort study;Cancer Medicine;2021-11-05